1. Academic Validation
  2. The E3 ubiquitin ligase RNF182 inhibits TLR-triggered cytokine production through promoting p65 ubiquitination and degradation

The E3 ubiquitin ligase RNF182 inhibits TLR-triggered cytokine production through promoting p65 ubiquitination and degradation

  • FEBS Lett. 2019 Nov;593(22):3210-3219. doi: 10.1002/1873-3468.13583.
Yang Cao 1 Yan Sun 2 Huiying Chang 1 Xin Sun 3 Shusen Yang 1
Affiliations

Affiliations

  • 1 Department of Cardiology, Cardiovascular Institute, The First Affiliated Hospital, Harbin Medical University, China.
  • 2 Microbiological Laboratory, Cardiovascular Institute, The First Affiliated Hospital, Harbin Medical University, China.
  • 3 Department of Cardiology, Shenzhen People's Hospital/The Second Affiliated Hospital of Jinan Medical College, China.
Abstract

The activation of Toll-like receptors (TLRs) leads to proinflammatory cytokine production, which is responsible for activating the innate immune system. Thus, TLR signaling is subject to multilayer regulatory control mechanisms that aim to prevent a protective response from causing injury. In the present study, we report that the E3 ubiquitin Ligase RNF182 is highly expressed in macrophages and is specifically upregulated by TLR stimuli (TLR4, TLR3 and TLR9 agonists). Knockdown of RNF182 selectively amplifies TLR signaling by promoting the production of proinflammatory cytokines but not type I interferons in macrophages. Mechanistically, RNF182 promotes the degradation of p65 via K48-linked ubiquitination, resulting in the inhibition of TLR-triggered innate immune responses. Our findings highlight a feedback-negative mechanism for terminating TLR-induced inflammation and maintaining the immunological balance.

Keywords

RNF182; TLRs; p65; ubiquitination.

Figures